Table 2. Number (Percentage) of Publications in the top 20 medical journals ranked by IF and EF for 26 most common neoplasms.
| AIF | AEF | ||||
| Rank | Cancer | Output (%) | Rank | Cancer | Output (%) |
| 1 | Leukemia | 533 (17.22) | 1 | Breast | 732 (15.61) |
| 2 | Breast | 496 (16.02) | 2 | Leukemia | 646 (13.78) |
| 3 | Intestinal | 348 (11.24) | 3 | Lung | 493 (10.51) |
| 4 | Lung | 266 (8.59) | 4 | Intestinal | 482 (10.28) |
| 5 | Non-Hodgkin | 214 (6.91) | 5 | Prostatic | 353 (7.53) |
| 6 | Prostatic | 170 (5.49) | 6 | Non-Hodgkin | 276 (5.89) |
| 7 | Liver | 162 (5.23) | 7 | CNS | 208 (4.44) |
| 8 | Myeloma | 123 (3.97) | 8 | Ovarian | 205 (4.37) |
| 9 | CNS | 105 (3.39) | 9 | Melanoma | 194 (4.14) |
| 10 | Ovarian | 86 (2.78) | 10 | Liver | 165 (3.52) |
| 11 | Pancreatic | 86 (2.78) | 11 | Myeloma | 156 (3.33) |
| 12 | Stomach | 81 (2.62) | 12 | Pancreatic | 151 (3.22) |
| 13 | Uterine | 73 (2.36) | 13 | Kidney | 112 (2.39) |
| 14 | Kidney | 61 (1.97) | 14 | Uterine | 109 (2.32) |
| 15 | Hodgkin | 60 (1.94) | 15 | Stomach | 80 (1.71) |
| 16 | Melanoma | 60 (1.94) | 16 | Hodgkin | 65 (1.39) |
| 17 | Esophageal | 48 (1.55) | 17 | Esophageal | 54 (1.15) |
| 18 | Testicular | 38 (1.23) | 18 | Urinary | 48 (1.02) |
| 19 | Soft Tissue | 29 (0.94) | 19 | Testicular | 36 (0.77) |
| 20 | Urinary | 21 (0.68) | 20 | Thyroid | 35 (0.75) |
| 21 | Mesothelioma | 11 (0.36) | 21 | Soft Tissue | 30 (0.64) |
| 22 | Mouth | 11 (0.36) | 22 | Mouth | 26 (0.55) |
| 23 | Thyroid | 9 (0.29) | 23 | Mesothelioma | 24 (0.51) |
| 24 | Laryngeal | 5 (0.16) | 24 | Laryngeal | 6 (0.13) |
| 25 | Gallbladder | 0 (0.00) | 25 | Gallbladder | 2 (0.04) |
| 26 | Vulvar | 0 (0.00) | 26 | Vulvar | 1 (0.02) |
| Total | 3096 (100) | Total | 4689 (100) | ||
AIF, output on each malignancy in the top twenty medical journals by IF in 2007; AEF, output on each malignancy in the top twenty medical journals by EF in 2007.